Valeant Pharmaceuticals Intl Inc (VRX) Facing Headwinds As Dermatology...
Analyst Gregg Gilbert of Deutsche Bank remains on the fence with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) after mixed second-quarter results. The company’s EPS of $1.03 beat out both consensus and...
View ArticleUlta Beauty Inc (ULTA) Fundamentals Remain Solid; Piper Jaffray Sees 47% Upside
As Ulta Beauty Inc (NASDAQ:ULTA) readies to release second quarter results this coming Thursday, analyst Erinn Murphy of Piper Jaffray has put out a bullish note, anticipating continued growth for the...
View Articlesalesforce.com, inc. (CRM) Represents a Solid Play for Investors in the Cloud...
As salesforce.com, inc. (NYSE:CRM) sets to release fiscal second-quarter earnings tomorrow evening, analyst Brian White of Drexel Hamilton is weighing in with his forecasts. The analyst is predicting...
View ArticleValeant Pharmaceuticals Intl Inc (VRX): Tampa Resolution to Pave the Way for...
After receiving a Complete Response Letter (CRL) from the FDA earlier this month, concerning CGMP (Current Good Manufacturing Practice) deficiencies at its Tampa facility, management at Valeant...
View ArticleHow Will Departure of Americas SVP Impact eBay Inc (EBAY)? Top Analyst Answers
With yesterday morning’s announcement that Hal Lawton, the senior vice president of eBay Inc’s (NASDAQ:EBAY) North America business heading on out for Macy’s, top analyst Colin Sebastian of Baird...
View ArticleIs There Light at the End of the Tunnel for Snap Inc?
Snap Inc (NYSE:SNAP) has been hard at work to develop a highly engaging format attractive to teens and young adults and it appears the company’s efforts are paying off. With a report released from...
View ArticleQUALCOMM, Inc.’s (QCOM) Multiple Litigations Are Keeping BMO on the Sidelines
Coming away from a meeting at QUALCOMM, Inc. (NASDAQ:QCOM) headquarters, top analyst Tim Long of BMO notes that senior executives exuded confidence regarding a number of “hot topics,” including: its...
View ArticleAlibaba Group Holding Ltd (BABA) Gets Price Target Lift Following Stellar FQ1...
On the heels of a solid fiscal first quarter beat from Alibaba Group Holding Ltd (NYSE:BABA), analyst Jason Helfstein of Oppenheimer is becoming increasingly bullish on the e-commerce giant’s...
View ArticleAlphabet Inc’s (GOOGL) Voice Commerce Collaboration with Walmart to Boost...
Top analyst Colin Sebastian of Baird is out with a bullish report on Alphabet Inc (NASDAQ:GOOGL) on the heels of two key announcements. First, Express local shopping service users who once had to shell...
View ArticleChipotle Mexican Grill, Inc. (CMG) Regaining Consumer Confidence, Says...
Chipotle Mexican Grill, Inc. (NYSE:CMG) stock continued its free fall yesterday reaching $297.09, its lowest point since December 2012. Like the E. coli outbreak of 2015, the mega restaurant chain was...
View ArticleRoth Capital Unfazed as Glu Mobile Inc. (GLUU) Restructuring Game Plan Puts...
Glu Mobile Inc. (NASDAQ:GLUU) is undergoing a major overhaul, as the company downsizes its work force by 46 employees, abandons its worldwide launch of Car Town Racing (CTR), closes the San Francisco...
View ArticleAbercrombie & Fitch Co. (ANF) 2Q17 Beat Shows Encouraging Momentum: William...
It is a great time to be an Abercrombie & Fitch Co. (NYSE:ANF) shareholder after the U.S. teen apparel retailer impressed with a second-quarter outclass yesterday, sending shares racing 17% and...
View ArticleBroadcom Ltd (AVGO) Wired Portfolio Well-Positioned to Gain Shares, Says Top...
Top analyst Michael Walkley of Canaccord is out with a bullish note after Broadcom Ltd (NASDAQ:AVGO) hit all the right marks with its third fiscal quarter performance for the year. Thanks to strength...
View ArticleWhat’s Next for QUALCOMM, Inc.’s (QCOM) Licensing Business? William Blair...
What is to become of QUALCOMM, Inc. (NASDAQ:QCOM), a chip-making empire, now that once December 31st hits, President Derek Aberle will be leaving the doors of a company that was already standing under...
View ArticleTeva Pharmaceutical Industries Ltd (ADR) (TEVA) Lacking Leadership and...
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) a dimming pharmaceutical giant has been rocked by increasing competition on the generic market and left without direction lacking a full-time CEO....
View ArticleTop Analyst Shares Two Cents on WDC Western Digital Corp (WDC) Amid Toshiba...
WDC Western Digital Corp (NASDAQ:WDC) nor Toshiba have made confirmation quite yet, but rumors are swirling regarding a pending deal between the two companies, whereby Toshiba would sell WDC its chip...
View ArticleAmazon.com, Inc.’s (AMZN) Whole Foods Takeover Will Be a Springboard to Big...
For Amazon.com, Inc. (NASDAQ:AMZN) there is currently no business like the food business, as the giant e-commerce platform closed a deal with Whole Foods Market (WFM) yesterday. The deal is part of...
View ArticleFitbit Inc (FIT) Shares Could Re-Rate Higher on Back of Digital Health...
Fitbit Inc (NYSE:FIT) is making bold moves to broaden its scope from just a fitness tracker provider to a comprehensive fitness-oriented platform. As the company introduces a host of new wireless...
View ArticleLululemon Athletica inc.’s (LULU) Q2 Results Could Translate to Good...
Analyst Camilo Lyon of Canaccord is out with a bearish report on Lululemon Athletica inc. (NASDAQ:LULU) ahead of second quarter earnings due this Thursday. Though Lyon would not be surprised to see a...
View ArticleAmazon.com, Inc. (AMZN) Gains Upper Hand in Capturing $700B Groceries Market...
On back of a key $13.7 billion acquisition of Whole Foods, Amazon.com, Inc. (NASDAQ:AMZN) is finally diving head first into the $700 billion US groceries market, after years of experimenting with food...
View ArticleGilead Sciences, Inc. (GILD) Gets the Edge in Oncology Sector With Kite...
Gilead Sciences, Inc. (NASDAQ:GILD) made a bold move by acquiring Kite Pharma Inc (NASDAQ:KITE) as a step towards building up its oncology franchise. The acquisition, which was approved unanimously by...
View ArticleTeva Pharmaceutical Industries Ltd’s (ADR) (TEVA) AUSTEDO Wins Key FDA...
Analyst Louise Chen of Cantor is out with a cautiously optimistic report on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after the pharmaceutical giant announced FDA approval of its new drug...
View ArticleFreeport-McMoran Inc (FCX) Grasberg Not a Done Deal; Berenberg Suggest Risks...
Despite having reached “an understanding on a framework” with the Indonesian government on Tuesday, Freeport-McMoRan Inc (NYSE:FCX) shareholders were clearly apprehensive sending the stock 4% southward...
View ArticleBest Buy Co Inc (BBY) to Lose Ground Long-Term Against Major Online Retailers
On Tuesday, Best Buy Co Inc (NYSE:BBY) reported a robust fiscal second quarter beat, which well surpassed both consensus and company guidance. Offsetting waning tablet sales, the company saw stronger...
View ArticleHimax Technologies, Inc. (ADR) (HIMX) Partnership With QUALCOMM, Inc. (QCOM)...
Upon formalizing its partnership on the 3D sensing camera with QUALCOMM, Inc. (NASDAQ:QCOM), excited shareholders pushed Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) stock 6% northward yesterday with a...
View ArticleProgenics Pharmaceuticals, Inc. (PGNX) Delay in NDA Filing Dose Not Reflect...
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) announced that it intends to push off its NDA submission on Azedra, a treatment for malignant pheochromocytoma and paraganglioma, by another quarter, as it...
View ArticleCatalyst Pharmaceuticals Inc (CPRX) Shakes Hands with FDA on SPA for...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shared some key announcements yesterday regarding its progress for drug candidate Firdapse. First, the company has secured a Special Protocol Assessment (SPA)...
View ArticleKite Pharma Inc (KITE): FDA Approval of Kymriah Is Good News for the Future...
Analyst John Newman of Canaccord takes yesterday’s FDA approval of Novartis’ chimeric antigen receptor T-cell (CAR-T) therapy Kymriah as a meaningful victory for Kite Pharma Inc’s (NASDAQ:KITE) fellow...
View ArticleGilead Sciences, Inc. (GILD) Has Solid Catalysts for Continued Growth;...
In a research report issued Thursday, analyst Y Katherine Xu of William Blair assumed coverage on shares of Gilead Sciences, Inc. (NASDAQ:GILD). Xu underscored forthcoming catalysts and explored...
View ArticleAmazon.com, Inc. (AMZN) to Capture Significant U.S. Grocery Market Share by...
With the acquisition of Whole Foods, Amazon.com, Inc.’s (NASDAQ:AMZN) is poised to take a bite out of the $600 billion U.S. grocery market. Analyst Kip Paulson of Cantor believes the e-commerce giant...
View ArticleLululemon Athletica inc. (LULU) Strong Q2 Numbers Don’t Demonstrate a...
On paper, Lululemon Athletica inc. (NASDAQ:LULU) had a solid second quarter, notes analyst Camilo Lyon of Canaccord. True, in Lulu’s second quarter, the company yielded 39c in EPS, beating out both...
View ArticleNutanix Inc (NTNX) Sharpens HCI Leadership Position Even as Competition...
Nutanix Inc (NASDAQ:NTNX) pulled off a strong second fiscal quarter showing resilience against continuously rising DRAM prices, proving that the cloud computing developer can stay at the forefront of...
View ArticlePalo Alto Networks Inc (PANW) New Product Development a Key to Continued...
Palo Alto Networks Inc (NYSE:PANW) shares popped up by nearly 14% after releasing solid fiscal fourth quarter results, which beat out consensus on a wide range of estimates. Over the past quarter, the...
View ArticleAdvanced Micro Devices, Inc. (AMD) Bull Run Won’t Last
Analysts and investors alike are asking if the time is ripe to dump Advanced Micro Devices, Inc. (NASDAQ:AMD) shares or hold out for a better day. It is no secret that the flailing stock has struggled...
View ArticleWill European Commission Force Alphabet Inc (GOOGL) to Alter Android? Top...
Alphabet Inc (NASDAQ:GOOGL) is under heavy fire by the European Union, as the newest anti-trust probe draws to a close. The current investigation surrounds allegations that Google is gaining an unfair...
View ArticleCantor Offers Bullish Forecast on Synergy Pharmaceuticals Inc (SGYP)...
Following the launch of its inaugural drug Trulance, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) second quarter earnings fell short of expectations, leading to a 16% decline in shares since the tenth of...
View ArticleDJI’s Spark Short Circuits Ambarella Inc (AMBA) Drone Revenue Leading to...
Despite announcing solid 2018 fiscal second quarter results, Ambarella Inc (NASDAQ:AMBA) spoiled the party by lowering its full-year fiscal 2018 guidance. Shareholders responded in a fury by dumping...
View ArticleMallinckrodt PLC (MNK) Inomax Sales to Reach $505.9 Million by 2017 Despite...
Mallinckrodt PLC (NYSE:MNK) shares plummeted 12% Tuesday after the company lost its bid in federal court to prevent its competitor Praxair from marketing a generic version of its respiratory treatment...
View ArticleThis Analyst Sees 1035% Upside for Palatin Technologies, Inc. (PTN) Following...
Palatin Technologies, Inc. (NYSEMKT:PTN) and Fosun Pharma have entered into an agreement to develop and commercialize the drug Rekynda, which treats female sexual dysfunction. According to the terms of...
View ArticleAlphabet Inc (GOOGL) Facing the Greatest Regulatory Risk Among Large Cap...
There is no doubt that the EU has Alphabet Inc (NASDAQ:GOOGL) in its “cross-hairs.” Coming on the heels of a $2.7 billion fine levied on Alphabet for using Google search to give illegal advantages to...
View ArticleCowen Shares Key Insights on Gilead Sciences, Inc. (GILD) Following...
Top analyst Phil Nadeau of Cowen is sharing key insights on Gilead Sciences, Inc. (NASDAQ:GILD) after organizing meetings between investors and senior management in Boston last week. Notably, the...
View ArticleCowen Sees High 80% Probability of FDA Approval for Insmed Incorporated’s...
Investors were all cheers last Tuesday as Insmed Incorporated (NASDAQ:INSM) released Phase III CONVERT top-line efficacy and safety data on its lead candidate drug amikacin liposome inhalation...
View ArticleActivision Blizzard, Inc. (ATVI) Destiny 2 Launch Could Provide Upside: Piper...
Over a million Activision Blizzard, Inc. (NASDAQ:ATVI) players have already rushed to purchase the much-anticipated Destiny 2 video game. Glitches from the original Destiny have been fixed, the...
View ArticleFuelCell Energy Inc (FCEL) Project Bookings Are Primary Catalysts for Growth:...
Analyst Craig Irwin of Roth Capital does not view FuelCell Energy Inc’s (NASDAQ:FCEL) weak fiscal third quarter as a central concern at this time. Noting that the clean energy manufacturer is currently...
View ArticleWilliam Blair Sees Limited Downside Potential for Finisar Corporation (FNSR)...
A glitch in 3-D production has pushed Finisar Corporation (NASDAQ:FNSR) into a first fiscal first-quarter setback. The optical networking company will now have to delay its 3-D manufacturing ramp-up...
View ArticleCowen Positive on Sarepta Therapeutics Inc (SRPT) Following Successful...
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares traded 10% higher last week after the company released “very positive” results on its newest Duchenne muscular dystrophy (DMD) therapy called golodirsen...
View ArticleRexahn Pharmaceuticals, Inc. (RNN) Phase 2a Update in Muscle Invasive Bladder...
Over the weekend at this year’s Congress of the European Society for Medical Oncology (ESMO), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) revealed the results of 10 patients from Stage 1 of its Phase 2a...
View ArticleIs New Teva Pharmaceutical Industries Ltd (ADR) (TEVA) CEO Walking into a...
After a month of an absolute free-fall in shares, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock grabbed a foothold yesterday after management announced the company’s newest President and...
View ArticleHere’s Why You Should Buy SAGE Therapeutics Inc (SAGE) Following Failure of...
SAGE Therapeutics Inc (NASDAQ:SAGE) shares plummeted by 24% today as the company announced the total failure of Phase 3 STATUS trial for its therapy SAGE-547 (brexanolone). The drug was developed as a...
View ArticleRosenblatt Sets Bullish Expectations on Oracle Corporation (ORCL) Ahead of...
On the back of three consecutive quarterly beats delivered from Oracle Corporation (NYSE:ORCL), there is no question that expectations are high as the software giant readies to release its first fiscal...
View Article
More Pages to Explore .....